K M C Speciality Hospitals (India) (BSE 524520)₹156.35−1.01%Hospital
In the Mar 2026 quarter (standalone), K M C Speciality Hospitals (India) reported sales of ₹82.12 Cr, up 34.5% from Mar 2025, and net profit of ₹14.99 Cr, up 200.4% year on year. For the year to Mar 2026, sales were ₹306 Cr and net profit ₹46.99 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 41.05 | 42.03 | 49.04 | 45.05 | 53.09 | 56.09 | 61.10 | 61.04 | 67.10 | 75.11 | 82.06 | 82.12 |
| Expenses | 31.03 | 30.99 | 35.03 | 33.03 | 40.01 | 44.01 | 44.98 | 46.01 | 50.02 | 54.01 | 57.01 | 55.97 |
| Operating Profit | 10.01 | 11.01 | 13.99 | 12.01 | 13.01 | 13.01 | 16.01 | 14.99 | 15.99 | 21.01 | 24.99 | 25.99 |
| OPM % | 25.0% | 26.0% | 29.0% | 26.0% | 24.0% | 22.0% | 26.0% | 25.0% | 25.0% | 28.0% | 30.0% | 31.0% |
| Other Income | 1.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.00 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 1.99 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 2.01 | 3.01 | 2.01 | 2.01 | 2.01 | 2.01 | 2.01 | 2.01 |
| Depreciation | 2.01 | 2.01 | 2.01 | 3.01 | 4.01 | 5.02 | 5.02 | 5.01 | 5.01 | 5.02 | 5.02 | 6.02 |
| Profit before tax | 9.01 | 9.01 | 12.01 | 9.01 | 7.01 | 5.01 | 10.01 | 9.01 | 10.01 | 15.01 | 18.01 | 20.01 |
| Tax % | 26.0% | 26.0% | 24.0% | 25.0% | 26.0% | 27.0% | 25.0% | 49.0% | 25.0% | 26.0% | 26.0% | 26.0% |
| Net Profit | 6.99 | 7.01 | 8.99 | 6.99 | 5.99 | 3.99 | 8.01 | 4.99 | 8.01 | 10.99 | 13.99 | 14.99 |
| EPS (Rs) | 0.44 | 0.43 | 0.59 | 0.44 | 0.35 | 0.25 | 0.47 | 0.29 | 0.47 | 0.67 | 0.85 | 0.91 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 43.09 | 55.08 | 71.06 | 82.13 | 96.21 | 103 | 136 | 156 | 177 | 232 | 306 | 306 |
| Expenses | 34.99 | 41.99 | 55.98 | 65.99 | 75.03 | 79.03 | 99.08 | 114 | 129 | 174 | 218 | 217 |
| Operating Profit | 8.01 | 12.01 | 14.01 | 16.01 | 20.99 | 23.01 | 37.01 | 41.99 | 48.03 | 56.99 | 87.99 | 87.98 |
| OPM % | 19.0% | 23.0% | 20.0% | 20.0% | 22.0% | 23.0% | 28.0% | 27.0% | 27.0% | 25.0% | 29.0% | 28.7% |
| Other Income | 0.99 | 0.00 | 0.00 | 1.99 | 0.99 | 1.99 | 1.99 | 2.99 | 3.99 | 2.99 | 4.99 | 4.96 |
| Interest | 2.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 2.01 | 10.02 | 8.01 | 8.04 |
| Depreciation | 3.01 | 3.01 | 4.01 | 4.01 | 5.02 | 6.02 | 7.02 | 8.03 | 9.03 | 19.05 | 22.09 | 21.07 |
| Profit before tax | 4.01 | 8.01 | 10.01 | 12.02 | 17.03 | 18.01 | 32.03 | 36.04 | 41.03 | 32.01 | 63.01 | 63.04 |
| Tax % | 21.0% | 33.0% | 32.0% | 30.0% | 30.0% | 29.0% | 26.0% | 26.0% | 25.0% | 32.0% | 26.0% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | 2.99 | 4.99 | 6.99 | 8.99 | 11.99 | 12.99 | 23.99 | 26.97 | 29.97 | 20.98 | 46.99 | 47.98 |
| EPS (Rs) | 0.21 | 0.34 | 0.42 | 0.54 | 0.73 | 0.79 | 1.47 | 1.65 | 1.87 | 1.32 | 2.88 | 2.90 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 16.00 | 15.99 | 15.99 | 16.03 | 16.01 | 16.00 | 16.02 | 16.02 | 16.01 | 16.01 | 15.99 | 16.01 |
| Reserves | −5.98 | −3.00 | 7.98 | 13.98 | 22.95 | 33.93 | 46.90 | 69.82 | 96.81 | 127 | 148 | 194 |
| Borrowings | 13.96 | 9.97 | 5.98 | 14.94 | 9.97 | 8.98 | 28.90 | 28.92 | 49.89 | 81.72 | 88.73 | 83.69 |
| Other Liabilities | 6.96 | 5.97 | 7.96 | 7.98 | 9.95 | 10.94 | 12.95 | 12.96 | 17.92 | 37.86 | 31.85 | 38.04 |
| Total Liabilities | 30.94 | 28.93 | 37.91 | 52.93 | 59.88 | 69.85 | 105 | 129 | 182 | 263 | 285 | 331 |
| Fixed Assets | 24.95 | 22.94 | 23.92 | 36.92 | 35.91 | 38.87 | 73.80 | 74.76 | 83.76 | 205 | 247 | 247 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.99 | 5.98 | 33.92 | 0.99 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 5.99 | 6.99 | 13.99 | 16.01 | 23.97 | 30.98 | 28.98 | 47.98 | 62.95 | 56.93 | 37.97 | 83.99 |
| Inventories | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 | 3.99 | 3.99 |
| Trade receivables | 1.01 | 2.01 | 2.01 | 2.01 | 2.01 | 2.01 | 3.01 | 4.02 | 4.02 | 4.02 | 6.03 | 7.03 |
| Cash & equivalents | 0.00 | 0.00 | 0.99 | 3.99 | 5.98 | 9.96 | 17.93 | 32.86 | 38.86 | 22.93 | 8.96 | 54.81 |
| Total Assets | 30.94 | 28.93 | 37.91 | 52.93 | 59.88 | 69.85 | 105 | 129 | 182 | 263 | 285 | 331 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 4.99 | 5.99 | 9.98 | 11.98 | 15.98 | 10.99 | 25.97 | 28.97 | 31.95 | 37.94 | 57.88 | 78.83 |
| Cash from investing activity | −1.01 | −1.01 | −4.01 | −19.04 | −9.02 | −8.02 | −43.10 | −29.03 | −48.08 | −56.10 | −51.11 | −17.02 |
| Cash from financing activity | −5.01 | −5.01 | −5.01 | 6.02 | −5.02 | −4.01 | 18.05 | −1.01 | 16.06 | 20.05 | −2.01 | −21.07 |
| Net cash flow | 0.00 | 0.00 | 1.01 | −1.01 | 1.01 | −1.01 | 1.01 | 0.00 | 0.00 | 3.01 | 4.01 | 41.02 |
| Capex | 0.97 | 0.83 | 4.30 | 15.78 | 3.23 | 3.47 | 40.87 | 13.49 | 44.14 | 75.30 | 63.90 | 16.65 |
| Free cash flow | 4.99 | 4.99 | 5.99 | −2.99 | 12.98 | 6.99 | −14.97 | 15.97 | −11.99 | −36.94 | −5.99 | 62.94 |
| CFO / OP % | 112.0% | 91.0% | 94.0% | 100.0% | 113.0% | 66.0% | 120.0% | 102.0% | 100.0% | 101.0% | 112.1% | 100.1% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 11 | 12 | 11 | 12 | 7 | 7 | 8 | 9 | 9 | 8 | 8 | 8 |
| Inventory days | 42 | 32 | 28 | 24 | 29 | 59 | 39 | 33 | 36 | 31 | 38 | 31 |
| Days payable | 169 | 158 | 134 | 143 | 161 | 115 | 117 | 96 | 102 | 113 | 153 | 82 |
| Cash conversion cycle | −114 | −111 | −93 | −106 | −124 | −47 | −67 | −52 | −55 | −72 | −104 | −41 |
| Working capital days | −70 | −60 | −46 | −37 | −28 | −18 | −15 | −27 | −22 | −73 | −22 | −19 |
| ROCE % | 8.0% | 24.0% | 34.9% | 28.9% | 29.0% | 32.9% | 24.9% | 31.9% | 27.0% | 21.9% | 16.9% | 25.9% |
For the Mar 2026 quarter, K M C Speciality Hospitals (India) reported sales of ₹82.12 Cr, up 34.5% year on year and net profit of ₹14.99 Cr, up 200.4% year on year. The operating margin was 31.0%.
K M C Speciality Hospitals (India)'s sales for the year to Mar 2026 were ₹306 Cr; over the last twelve months they were ₹306 Cr.
Net profit for the year to Mar 2026 was ₹46.99 Cr, and ₹47.98 Cr over the last twelve months. Earnings per share over the same trailing period were ₹2.90.
K M C Speciality Hospitals (India) reported borrowings of ₹83.69 Cr at Mar 2026, against cash and equivalents of ₹54.81 Cr.
Cash from operations was ₹78.83 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹62.94 Cr.